JAK3 and non-small cell lung carcinoma: The inappropriate activation of Stat3 or IL-7-mediated IL-7R-JAK3/STAT5 pathway is associated with an unfavorable prognosis in NSCLC patients and correlated with chemoresistance and radioresistance (24).